GE Healthcare of Chalfont St. Giles, U.K., debuted new molecular imaging offerings at the World Molecular Imaging Congress (WMIC) being held in Kyoto, Japan.
The company showcased Triumph II, a solid-state trimodality digital imaging system that features enhanced image quality and quantitative capabilities, a wider bore size to fit larger animals, higher PET sensitivity, and new SPECT collimators for improved resolution and sensitivity, GE said. It includes a proprietary 3D PET reconstruction algorithm, according to the firm.
GE is also highlighting eXplore speCZT/CT 120, an integrated SPECT/CT system with a full-ring solid-state detector for small animal SPECT, according to GE; it is combined with CT 120 for dual-modality imaging and fusion, and the system is equipped with GE's new SPECT/CT attenuation correction feature.
GE also introduced its TracerCenter for preclinical imaging, a package that combines site planning, cyclotrons, an infrastructure platform, and reagents to start up and run a preclinical imaging center. In addition, GE highlighted TracerLab FX N Pro, an enhanced version of TracerLab FX F-N, a generic platform for F-18 tracers for researchers. TracerLab FX N Pro will be available later this year.
The company also showcased an expanded FASTlab platform: In addition to the existing cassettes for F-18 FDG and F-18 sodium fluoride (NaF), GE plans to offer cassettes for F-18 fluorothymidine (FLT) and F-18 fluoromisonidazole (FMISO) in 2011, as well as an alternative FDG cassette that will use the TracerLab MX system synthesis method.
Related Reading
GE, Arineta sign CT agreement, August 24, 2010
GE, Orion ink distribution deal, August 4, 2010
GE, Intel form new telehealth joint venture, August 2, 2010
GE settles oil-for-food charges with SEC, July 27, 2010
GE receives MRI grant, July 22, 2010
Copyright © 2010 AuntMinnie.com
